Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Brooklyn Immunotherapeutics Inc
(NQ:
BTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 14, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Brooklyn Immunotherapeutics Inc
< Previous
1
2
3
Next >
Brooklyn ImmunoTherapeutics Stock Rises After Novellus Therapeutics Buyout Deal
June 14, 2021
Brooklyn ImmunoTherapeutics LLC (NYSE: BTX) has executed a non-binding letter of intent to acquire Novellus Therapeutics, a company developing engineered...
Via
Benzinga
Brooklyn Immunotherapeutics Stock Is a Worthy Bet on Genetics Research
June 07, 2021
BTX stock holders will certainly want to brace for volatility. Still, the outlook's bullish as the company pursues its game-changing research.
Via
InvestorPlace
64 Biggest Movers From Friday
June 07, 2021
Gainers Senseonics Holdings, Inc. (NYSE: SENS) jumped 42% to settle at $2.91 on Friday after the company disclosed results from a PROMISE study evaluating its Eversense CGM...
Via
Benzinga
66 Biggest Movers From Yesterday
June 03, 2021
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) surged 95.2% to close at $62.55 on Wednesday amid renewed interest from retail investors. AMC Entertainment shares jumped...
Via
Benzinga
Brooklyn ImmunoTherapeutics CEO Howard J. Federoff Provides Roadmap for the Company’s Future During May 25, 2021 Shareholder Update Call
May 26, 2021
From
Brooklyn ImmunoTherapeutics, Inc.
Via
Business Wire
68 Biggest Movers From Yesterday
June 02, 2021
Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares surged 115.2% to close at $7.64 on Tuesday after the company announced its subsidiary, Gibson Technical Services, reached...
Via
Benzinga
22 Stocks Moving in Wednesday's Pre-Market Session
May 26, 2021
Gainers Nabriva Therapeutics plc (NASDAQ: NBRV) rose 48.8% to $2.20 in pre-market trading. Sinovant Sciences and Nabriva Therapeutics disclosed topline results from Phase 3 trial...
Via
Benzinga
54 Biggest Movers From Yesterday
May 26, 2021
Gainers Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended...
Via
Benzinga
Brooklyn ImmunoTherapeutics Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing
May 24, 2021
From
Brooklyn ImmunoTherapeutics, Inc.
Via
Business Wire
52 Biggest Movers From Yesterday
May 25, 2021
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA,...
Via
Benzinga
Exposures
Product Safety
Michael Andreeff, M.D., Ph.D to Join the Scientific Advisory Board of Brooklyn ImmunoTherapeutics, Inc.
May 21, 2021
From
Brooklyn ImmunoTherapeutics, Inc.
Via
Business Wire
48 Biggest Movers From Friday
May 24, 2021
Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares surged 127.3% to close at $60.00 on Friday after the company announced new results from a Phase 2 study evaluating its lead drug...
Via
Benzinga
New CEO and Exclusive License Will Bolster Brooklyn Immunotherapeutics
May 18, 2021
Is change at the C-suite level a good thing for a company? The facts seem to indicate that it's a positive development for BTX stock holders.
Via
InvestorPlace
Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call Tuesday May 25, 2021 at 4:30 PM ET
May 18, 2021
From
Brooklyn ImmunoTherapeutics, Inc.
Via
Business Wire
58 Biggest Movers From Yesterday
May 18, 2021
Gainers Peabody Energy Corporation (NYSE: BTU) shares gained 32.3% to settle at $8.60 on Monday. Nuvve Holding Corp. (NASDAQ: NVVE) shares jumped 30.9% to close at $10.80 on...
Via
Benzinga
Publication In Breast Cancer Research Indicate Brooklyn ImmunoTherapeutics' IRX-2 May Hold Promise In Early-Stage Breast Cancer
May 11, 2021
Brooklyn ImmunoTherapeutics Inc (NYSE: BTX) has announced a publication in Breast Cancer Research, which demonstrates how multiplex immunofluorescence (mIF)...
Via
Benzinga
74 Biggest Movers From Friday
May 17, 2021
Gainers MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter. HyreCar Inc. (NASDAQ: HYRE) shares...
Via
Benzinga
Brooklyn ImmunoTherapeutics Announces Publication of Results of IRX-2 Monotherapy in Early Stage Breast Cancer in Breast Cancer Research
May 11, 2021
From
Brooklyn ImmunoTherapeutics, Inc.
Via
Business Wire
Why Brooklyn ImmunoTherapeutics Stock Crushed It in April
May 08, 2021
This clinical-stage biotech was one of April's brightest stars.
Via
The Motley Fool
Erich Mohr, Ph.D., to Join the Board of Directors of Brooklyn ImmunoTherapeutics
May 07, 2021
From
Brooklyn ImmunoTherapeutics, Inc.
Via
Business Wire
28 Stocks Moving in Wednesday's Pre-Market Session
May 05, 2021
Gainers Athenex, Inc. (NASDAQ: ATNX) shares rose 46.6% to $5.44 in pre-market trading after the company announced it acquired Kuur Therapeutics. iBio, Inc. (NYSE: IBIO) rose 29.5...
Via
Benzinga
70 Biggest Movers From Yesterday
May 06, 2021
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters...
Via
Benzinga
Up 1,300% in the Past Month, Is This Mysterious Biotech a Buy?
May 05, 2021
An unknown biotech has turned its early investors into millionaires over the past month. Can it continue its momentum?
Via
The Motley Fool
50 Stocks Moving In Wednesday's Mid-Day Session
May 05, 2021
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares jumped 64.9% to $7.75 after the company reported an order for 200,000 sugarBEAT sensors. Chiasma, Inc. (NASDAQ: CHMA) gained 53...
Via
Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
May 04, 2021
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares jumped 75.4% to $2.1750. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug candidates that target...
Via
Benzinga
Exposures
COVID-19
64 Biggest Movers From Yesterday
May 05, 2021
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug...
Via
Benzinga
Exposures
COVID-19
26 Stocks Moving in Tuesday's Pre-Market Session
May 04, 2021
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares rose 60.5% to $1.99 in pre-market trading. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug...
Via
Benzinga
Exposures
COVID-19
52 Biggest Movers From Yesterday
May 04, 2021
Gainers Regional Health Properties, Inc. (NYSE: RHE) shares climbed 102.5% to close at $14.62 on Monday after jumping 38% on Friday. Image Sensing Systems, Inc. (NASDAQ: ISNS)...
Via
Benzinga
Mid-Afternoon Market Update: Crude Oil Rises 1.5%; AVROBIO Shares Plummet
May 03, 2021
Toward the end of trading Monday, the Dow traded up 0.82% to 34,152.49 while the NASDAQ fell 0.36% to 13,912.07. The S&P also rose, gaining 0.41% to 4,198.29. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Mid-Day Market Update: Nasdaq Drops 50 Points; Ocugen Shares Spike Higher
May 03, 2021
Midway through trading Monday, the Dow traded up 0.92% to 34,187.80 while the NASDAQ fell 0.37% to 13,910.67. The S&P also rose, gaining 0.36% to 4,196.13. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.